Quantcast
Last updated on April 24, 2014 at 21:24 EDT

Latest Mepolizumab Stories

2014-01-20 12:24:00

LONDON, Jan. 20, 2014 /PRNewswire/ -- Reportbuyer.com just published a new market research report: Asthma Therapeutics Market to 2019 - Breakthrough Biologics to Enhance Treatment of Severe Asthma and Drive Market Growth Asthma Therapeutics Market to 2019 - Breakthrough Biologics to Enhance Treatment of Severe Asthma and Drive Market Growth Summary GBI Research, a leading business intelligence provider, has released its latest research report, "Asthma Therapeutics Market to 2019 -...

2013-10-30 23:34:03

MarketResearch.com announces the addition of a new market research report in Pharmaceuticals to their product offering: Asthma Therapeutics Market to 2019; http://www.marketresearch.com/land/product.asp?productid=7840710&progid=85830. Rockville, MD (PRWEB) October 30, 2013 Asthma Therapeutics Market to 2019 The asthma market is forecast to grow marginally to 2019 across the leading eight developed nations, from $16.6 billion in 2012 to a projected value of $21.6 billion in 2019. This...

2013-10-10 16:24:10

ALBANY, New York, October 10, 2013 /PRNewswire/ -- New Report Added in ResearchMoz Reports Database Asthma Therapeutics Market to 2019 - Breakthrough Biologics to Enhance Treatment of Severe Asthma and Drive Market Growth ResearchMoz announces that it has published a new study Asthma Therapeutics Market to 2019 - Breakthrough Biologics to Enhance Treatment of Severe Asthma and Drive Market Growth...

Asthma Patients May Breathe More Easily Thanks To Game Changing Drug
2013-05-22 15:08:56

Lee Rannals for redOrbit.com — Your Universe Online Researchers said on Tuesday that a new type of asthma drug could be a potential game changer for patients with moderate to severe respiratory disease. The injectable drug, known as dupilumad, slashed asthmatic episodes by 87 percent in a mid-stage trial of 104 patients. The team wrote about the latest trial's results in the New England Journal of Medicine (NEJM). "Asthma that is difficult to treat is increasingly recognized as...

2013-05-10 16:24:28

LONDON and SOUTH SAN FRANCISCO, Calif., May 10, 2013 /PRNewswire/ -- GlaxoSmithKline plc (LSE/NYSE: GSK) and Theravance, Inc. (NASDAQ: THRX) today announced that the US Food and Drug Administration (FDA) has approved BREO(TM) ELLIPTA(TM) as an inhaled long-term, once-daily maintenance treatment of airflow obstruction in patients with chronic obstructive pulmonary disease (COPD), including chronic bronchitis and/or emphysema. It is also indicated to reduce exacerbations of COPD in patients...

2010-06-08 07:00:00

BERKELEY, Calif., June 8 /PRNewswire/ -- Aerovance Inc. today announced top-line results from its Phase 2b clinical trial that show the inhaled dry powder formulation of Aerovant (pitrakinra inhalation powder) is effective in a pre-defined subset of patients with eosinophilic asthma. Data from AeroTrial(TM), a 534-patient, double-blind, randomized, placebo-controlled, dose-ranging study, showed a 37% reduction (p < 0.004) in the incidence of asthma exacerbations in patients on Aerovant...

2009-12-09 18:15:10

A drug being tested to treat cancer could also help patients suffering from asthma, research has suggested A drug being tested to treat cancer could also help patients suffering from asthma, research has suggested. Scientists at the University of Edinburgh found that the drug "“ R-Roscovitine "“ helps to kill certain immune cells which can exacerbate symptoms associated with asthma. The findings could lead to an alternative way to treat asthma in patients who are resistant to...

2009-03-05 08:26:04

McMaster University researchers have found patients with a very severe asthma benefit from injections of the antibody, mepolizumab.The study by Dr. Param Nair and colleagues based at The Firestone Institute for Respiratory Disease, St. Joseph's Healthcare, found patients who require a lot of medication, including prednisone, to control their disease benefit from the injections.The research published in the New England Journal of Medicine (NEJM), investigated asthmatics with a persisting type...